Terms: = Head and neck cancer AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321 AND Prognosis
6 results:
1. Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a ddb2-mediated mechanism.
Jones TM; Espitia CM; Ooi A; Bauman JE; Carew JS; Nawrocki ST
Cell Death Dis; 2022 Apr; 13(4):350. PubMed ID: 35428778
[TBL] [Abstract] [Full Text] [Related]
2. An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features.
Chen X; Li Y; Li X; Cao X; Xiang Y; Xia W; Li J; Gao M; Sun Y; Liu K; Qiang M; Liang C; Miao J; Cai Z; Guo X; Li C; Xie G; Lv X
Oral Oncol; 2021 Jul; 118():105335. PubMed ID: 34023742
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of Saliva Gene Expression during head and neck cancer Radiotherapy: A Pilot Study.
Lacombe J; Brooks C; Hu C; Menashi E; Korn R; Yang F; Zenhausern F
Radiat Res; 2017 Jul; 188(1):75-81. PubMed ID: 28504589
[TBL] [Abstract] [Full Text] [Related]
4. Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
Peng H; Chen L; Li WF; Guo R; Mao YP; Zhang Y; Guo Y; Sun Y; Ma J
Cancer; 2017 May; 123(9):1643-1652. PubMed ID: 28001301
[TBL] [Abstract] [Full Text] [Related]
5. E3 Ubiquitin Ligases as Molecular Targets in Human Oral cancers.
Masumoto K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
[TBL] [Abstract] [Full Text] [Related]
6. Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma.
Yamashita H; Noguchi S; Murakami N; Toda M; Uchino S; Watanabe S; Kawamoto H
Cancer; 1999 Sep; 86(5):842-9. PubMed ID: 10463984
[TBL] [Abstract] [Full Text] [Related]
